Stockreport

Kazia Therapeutics surges 53% on positive data from phase 1 trial of brain cancer drug [Seeking Alpha]

Kazia Therapeutics Limited - American Depositary Shares  (KZIA) 
US:NASDAQ Investor Relations: kaziatherapeutics.com
PDF Kazia Therapeutics surges 53% on positive data from phase 1 trial of brain cancer drugAug. 05, 2022 9:07 AM ETBy:Dania NadeemSA News Editorvitanovski [Read more]